Long-term survival in adult neuroblastoma with multiple recurrences

Case Reports in Oncology

Volumn 3, Issue 1, 2010, Pages 45-48

  Venat Bouvet L ^a   Le Brun Ly, V ^a   Martin, J ^a   Gasnier, O ^a   Falkowsky, S ^a   Tubiana Mathieu, N ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

Adults; Long term survival; Neuroblastoma

Indexed keywords

(3 IODOBENZYL)GUANIDINE; CARBOPLATIN; CHROMOGRANIN A; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IODINE 123; SYNAPTOPHYSIN; VINCRISTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MULTIPLE CYCLE TREATMENT; NEEDLE BIOPSY; NEUROBLASTOMA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; THORACOTOMY;

EID: 77958547670     PISSN: None     EISSN: 16626575     Source Type: Journal    
DOI: 10.1159/000286142     Document Type: Article

References (15)

1. Davis S, Rogers M, Pendergrass T: The incidence and epidemiologic characteristics of neuroblastoma in the United States. Am J Epidemiol 1987;6:1063-1074.
2. Castleberry RP: Biology and treatment of neuroblastoma. Pediatr Clin North Am 1997;44:919-937.
3. Francks LM, Bollen A, Seeger RC, Tram DO, Matthay KK: Neuroblastoma in adults and adolescents: an indolent course with poor survival. Cancer 1997;79:2028-2035.
4. Simon T, Hero B, et al: Tumor markers are poor predictors for relapse or progression in neuroblastoma. Eur J Cancer 2003;39:1899-1903.
5. Brink I, Hoegerle S, Kliisch J, et al: Imaging of pheochromocytoma and paraganglioma. Familial Cancer 2005;4:61-68.
6. Fukuchi K, Inenaga T, Suzuki Y, et al: Paraganglioma seen with FDG Dual-Head Gamma camera coincidence imaging after false-negative results of I-123 MIBG Imaging. Clin Nucl Medicine 2001;26:966-967.
7. Shulkin BL, Koeppe RA, Francis IR, et al: Pheochromocytomas that do not accumulate metaiodobenzylguanidine: localization with PET and administration of FDG. Radiology 1993;186:711.
8. Pakak K, Eisenhoffer G, Goldstein DS: Functional imaging of endocrine tumors: role of positron emission tomography. Endocrin Reviews 2004;25:568-580.
9. Ilias I, Yu J, Carrasquillo JA, et al: Superiority of 6-(18F)-fluorodopamine positron emission tomography versus (131I)- metaiodobenzyyguanidine scintigraphy in the localization of metastatic pheochromocytoma. J Clin Endocrinol Metab 2003;88:4083-4087.
10. Fuertes Manuel J, Mena Gonzales E, Camacho Marti V, et al: 123I-MIBG SPECTCT combined with gamma probe for radioguided localization of pheochromocytoma. Rev Esp Med Nucl 2005;24:418-421.
11. Ricard M, Tenenbaum F, Schlumberger M, et al: Intraoperative detection of pheochromocytoma with iodine-125 labelled meta-iodobenzylguanidine: a feasibility study. Eur J Nucl Med 1993;20:426-430.
12. Haase GM, Perez C, Atkinson JB: Current aspects of biology, risk assessment, and treatment of neuroblastoma. Semin Surg Oncol 1999;16:91-104.
13. Kushner BH, Kramer K, LaQuaglia MP, et al: Neuroblastoma in adolescents and adults: The Memorian Sloan-Kettering experience. Med Pediatr Oncol 2003;41:508-515.
14. Tang CK, Hajdu SI: Neuroblastoma in adolescence and adulthood. NY State J Med 1975;75:1434-1438.
15. Esiashvili N, Gooman M, Ward K, Marcus RB Jr, Johnstone PA: Neuroblastoma in adults: incidence and survival analysis based on SEER data. Pediatr Blood Cancer 2007;49:41-46.